LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 27

Search options

  1. Article ; Online: Co-Immunoprecipitation (Co-Ip) in Mammalian Cells.

    Lo Sardo, Federica

    Methods in molecular biology (Clifton, N.J.)

    2023  Volume 2655, Page(s) 67–77

    Abstract: The cell is a fantastic place where molecules dynamically move through the various cellular structures and compartments and meet each other, either transiently or in more stable complexes. These complexes have always a specific biological function; thus, ...

    Abstract The cell is a fantastic place where molecules dynamically move through the various cellular structures and compartments and meet each other, either transiently or in more stable complexes. These complexes have always a specific biological function; thus, it is important to identify and characterize the interaction between molecules, either DNA/RNA, DNA/DNA, protein/DNA, protein/protein, and so on. polycomb group proteins (PcG proteins) are epigenetic repressors involved in important physiologic processes as development and differentiation. They act on the chromatin through the formation of a repressive environment involving histone modification, recruitment of co-repressors, and chromatin-chromatin interactions. PcG form multiprotein complexes, whose characterization required several approaches. In this chapter, I will describe the co-immunoprecipitation (Co-IP) protocol, an easy method used to identify and analyze multiprotein complexes. In Co-IP, an antibody is used to isolate its target antigen, along with its binding partners, from a mixed sample. The binding partners purified with the immunoprecipitated protein can be identified by Western blot or by mass spectrometry.
    MeSH term(s) Animals ; Protein Binding ; Polycomb-Group Proteins/genetics ; Chromatin/genetics ; DNA/metabolism ; Immunoprecipitation ; Multiprotein Complexes/metabolism ; Mammals/genetics
    Chemical Substances Polycomb-Group Proteins ; Chromatin ; DNA (9007-49-2) ; Multiprotein Complexes
    Language English
    Publishing date 2023-05-22
    Publishing country United States
    Document type Journal Article
    ISSN 1940-6029
    ISSN (online) 1940-6029
    DOI 10.1007/978-1-0716-3143-0_6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The Chromosome Conformation Capture (3C) in Drosophila melanogaster.

    Lo Sardo, Federica

    Methods in molecular biology (Clifton, N.J.)

    2020  Volume 2157, Page(s) 9–17

    Abstract: The discovery of the DNA double helix by Watson and Crick in 1953 was the first report showing that the genomic information is not contained in a stretched linear molecule. After that, a huge advance in the knowledge of the structure of the eukaryotic ... ...

    Abstract The discovery of the DNA double helix by Watson and Crick in 1953 was the first report showing that the genomic information is not contained in a stretched linear molecule. After that, a huge advance in the knowledge of the structure of the eukaryotic genome in the nuclear space has been made over the last decades, bringing us to the widely accepted concept that the genome is packaged into hierarchical levels of higher-order three-dimensional structures. The spatial organization of the eukaryotic genome has direct influence on fundamental nuclear processes that include transcription, replication, and DNA repair. The idea that structural alterations of chromosomes may cause disease goes back to the early nineteenth century. Big effort has been devoted to the study of the three-dimensional architecture of the genome and its functional implications. In this chapter, I will describe the chromosome conformation capture (3C), one of the first techniques used to detect and measure the frequency of interactions between genomic sequences that are kept in spatial proximity in the nucleus.
    MeSH term(s) Animals ; Chromatin/chemistry ; Chromatin/genetics ; Chromatin/metabolism ; Chromosomes/chemistry ; Chromosomes/genetics ; Chromosomes/metabolism ; DNA/chemistry ; DNA/metabolism ; Drosophila melanogaster ; Humans
    Chemical Substances Chromatin ; DNA (9007-49-2)
    Language English
    Publishing date 2020-08-17
    Publishing country United States
    Document type Journal Article
    ISSN 1940-6029
    ISSN (online) 1940-6029
    DOI 10.1007/978-1-0716-0664-3_2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: In vivo

    Blandino, Giovanni / Lo Sardo, Federica

    Journal of thoracic disease

    2019  Volume 11, Issue Suppl 3, Page(s) S461–S464

    Language English
    Publishing date 2019-04-09
    Publishing country China
    Document type Editorial ; Comment
    ZDB-ID 2573571-8
    ISSN 2077-6624 ; 2072-1439
    ISSN (online) 2077-6624
    ISSN 2072-1439
    DOI 10.21037/jtd.2018.11.17
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Safety and Tolerability of COVID-19 Vaccine in Mast Cell Disorders Real-Life Data from a Single Centre in Italy.

    Nicola, Stefania / Mazzola, Marina / Lo Sardo, Luca / Montabone, Erika / Badiu, Iuliana / Corradi, Federica / Azzolina, Maria Carmen Rita / Dall'Acqua, Maurizio Gaspare / Rolla, Giovanni / Ridolfi, Irene / Quinternetto, Anna / Brussino, Luisa

    Vaccines

    2024  Volume 12, Issue 2

    Abstract: ... ...

    Abstract Background
    Language English
    Publishing date 2024-02-16
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2703319-3
    ISSN 2076-393X
    ISSN 2076-393X
    DOI 10.3390/vaccines12020202
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: MAURIVAX: A Vaccination Campaign Project in a Hospital Environment for Patients Affected by Autoimmune Diseases and Adult Primary Immunodeficiencies.

    Ridolfi, Irene / Lo Sardo, Luca / Nicola, Stefania / Borrelli, Richard / Comola, Ludovica / Marmora, Valentina / Badiu, Iuliana / Corradi, Federica / Azzolina, Maria Carmen Rita / Brussino, Luisa

    Vaccines

    2023  Volume 11, Issue 10

    Abstract: Background: ...

    Abstract Background:
    Language English
    Publishing date 2023-10-11
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2703319-3
    ISSN 2076-393X
    ISSN 2076-393X
    DOI 10.3390/vaccines11101579
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Analysis of Single-Locus Replication Timing in Asynchronous Cycling Cells.

    Federica, Lo Sardo

    Methods in molecular biology (Clifton, N.J.)

    2016  Volume 1480, Page(s) 55–65

    Abstract: In higher eucaryotes, not all the genome is replicated simultaneously: there are parts of the genome that replicate at the beginning of S-phase (early S-phase), others that are replicated later. In each cell, early replicating genomic regions are ... ...

    Abstract In higher eucaryotes, not all the genome is replicated simultaneously: there are parts of the genome that replicate at the beginning of S-phase (early S-phase), others that are replicated later. In each cell, early replicating genomic regions are alternated to late-replicating regions. In general, eucaryotic genomes are organized into structural domains where genes showing the same epigenetic state replicate at the same time.Here, we will describe the protocol that we routinely used for the analysis of replication timing of specific loci in Drosophila embryonic cell lines (S2 and S3) based on BrdU labeling and FACS sorting of different S-phase fractions (early, mid, late) of asynchronous cycling cells.
    Language English
    Publishing date 2016
    Publishing country United States
    Document type Journal Article
    ISSN 1940-6029
    ISSN (online) 1940-6029
    DOI 10.1007/978-1-4939-6380-5_5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: YAP and TAZ: Monocorial and bicorial transcriptional co-activators in human cancers.

    Lo Sardo, Federica / Canu, Valeria / Maugeri-Saccà, Marcello / Strano, Sabrina / Blandino, Giovanni

    Biochimica et biophysica acta. Reviews on cancer

    2022  Volume 1877, Issue 4, Page(s) 188756

    Abstract: The transcriptional regulators YAP and TAZ are involved in numerous physiological processes including organ development, growth, immunity and tissue regeneration. YAP and TAZ dysregulation also contribute to tumorigenesis, thereby making them attractive ... ...

    Abstract The transcriptional regulators YAP and TAZ are involved in numerous physiological processes including organ development, growth, immunity and tissue regeneration. YAP and TAZ dysregulation also contribute to tumorigenesis, thereby making them attractive cancer therapeutic targets. Arbitrarily, YAP and TAZ are often considered as a single protein, and are referred to as YAP/TAZ in most studies. However, increasing experimental evidences documented that YAP and TAZ perform both overlapping and distinct functions in several physiological and pathological processes. In addition to regulating distinct processes, YAP and TAZ are also regulated by distinct upstream cues. The aim of the review is to describe the distinct roles of YAP and TAZ focusing particularly on cancer. Therapeutic strategies targeting either YAP and TAZ proteins or only one of them should be carefully evaluated. Selective targeting of YAP or TAZ may in fact impair different pathways and determine diverse clinical outputs.
    MeSH term(s) Adaptor Proteins, Signal Transducing/genetics ; Adaptor Proteins, Signal Transducing/metabolism ; Humans ; Neoplasms/drug therapy ; Neoplasms/genetics ; Neoplasms/metabolism ; Phosphoproteins/metabolism ; Transcription Factors/genetics ; Transcription Factors/metabolism ; YAP-Signaling Proteins
    Chemical Substances Adaptor Proteins, Signal Transducing ; Phosphoproteins ; Transcription Factors ; YAP-Signaling Proteins
    Language English
    Publishing date 2022-06-28
    Publishing country Netherlands
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 2918802-7
    ISSN 1879-2561 ; 0304-419X
    ISSN (online) 1879-2561
    ISSN 0304-419X
    DOI 10.1016/j.bbcan.2022.188756
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting.

    Lo Sardo, Federica / Strano, Sabrina / Blandino, Giovanni

    Cancers

    2018  Volume 10, Issue 5

    Abstract: Lung cancer is the leading cause of cancer death in the world and there is no current treatment able to efficiently treat the disease as the tumor is often diagnosed at an advanced stage. Moreover, cancer cells are often resistant or acquire resistance ... ...

    Abstract Lung cancer is the leading cause of cancer death in the world and there is no current treatment able to efficiently treat the disease as the tumor is often diagnosed at an advanced stage. Moreover, cancer cells are often resistant or acquire resistance to the treatment. Further knowledge of the mechanisms driving lung tumorigenesis, aggressiveness, metastasization, and resistance to treatments could provide new tools for detecting the disease at an earlier stage and for a better response to therapy. In this scenario, Yes Associated Protein (YAP) and Trascriptional Coactivator with PDZ-binding motif (TAZ), the final effectors of the Hippo signaling transduction pathway, are emerging as promising therapeutic targets. Here, we will discuss the most recent advances made in YAP and TAZ biology in lung cancer and, more importantly, on the newly discovered mechanisms of YAP and TAZ inhibition in lung cancer as well as their clinical implications.
    Language English
    Publishing date 2018-05-06
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers10050137
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Hippo pathway dysregulation in gastric cancer: from Helicobacter pylori infection to tumor promotion and progression.

    Messina, Beatrice / Lo Sardo, Federica / Scalera, Stefano / Memeo, Lorenzo / Colarossi, Cristina / Mare, Marzia / Blandino, Giovanni / Ciliberto, Gennaro / Maugeri-Saccà, Marcello / Bon, Giulia

    Cell death & disease

    2023  Volume 14, Issue 1, Page(s) 21

    Abstract: The Hippo pathway plays a critical role for balancing proliferation and differentiation, thus regulating tissue homeostasis. The pathway acts through a kinase cascade whose final effectors are the Yes-associated protein (YAP) and its paralog ... ...

    Abstract The Hippo pathway plays a critical role for balancing proliferation and differentiation, thus regulating tissue homeostasis. The pathway acts through a kinase cascade whose final effectors are the Yes-associated protein (YAP) and its paralog transcriptional co‑activator with PDZ‑binding motif (TAZ). In response to a variety of upstream signals, YAP and TAZ activate a transcriptional program that modulates cellular proliferation, tissue repair after injury, stem cell fate decision, and cytoskeletal reorganization. Hippo pathway signaling is often dysregulated in gastric cancer and in Helicobacter pylori-induced infection, suggesting a putative role of its deregulation since the early stages of the disease. In this review, we summarize the architecture and regulation of the Hippo pathway and discuss how its dysregulation fuels the onset and progression of gastric cancer. In this setting, we also focus on the crosstalk between Hippo and other established oncogenic signaling pathways. Lastly, we provide insights into the therapeutic approaches targeting aberrant YAP/TAZ activation and discuss the related clinical perspectives and challenges.
    MeSH term(s) Humans ; Cell Transformation, Neoplastic ; Helicobacter Infections/genetics ; Helicobacter pylori ; Hippo Signaling Pathway ; Protein Serine-Threonine Kinases/metabolism ; Stomach Neoplasms/genetics ; Stomach Neoplasms/microbiology ; Transcription Factors/genetics ; Transcription Factors/metabolism
    Chemical Substances Protein Serine-Threonine Kinases (EC 2.7.11.1) ; Transcription Factors
    Language English
    Publishing date 2023-01-12
    Publishing country England
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 2541626-1
    ISSN 2041-4889 ; 2041-4889
    ISSN (online) 2041-4889
    ISSN 2041-4889
    DOI 10.1038/s41419-023-05568-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Activated MKK3/MYC crosstalk impairs dabrafenib response in BRAFV600E colorectal cancer leading to resistance.

    Pranteda, Angelina / Piastra, Valentina / Serra, Martina / Bernardini, Roberta / Lo Sardo, Federica / Carpano, Silvia / Diodoro, Maria Grazia / Bartolazzi, Armando / Milella, Michele / Blandino, Giovanni / Bossi, Gianluca

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

    2023  Volume 167, Page(s) 115480

    Abstract: Colorectal cancer (CRC) patients with BRAF mutations develop resistance to BRAF inhibitors at a very early stage. Understanding the molecular mechanisms involved in BRAF inhibitor resistance is critical for the development of novel therapeutic ... ...

    Abstract Colorectal cancer (CRC) patients with BRAF mutations develop resistance to BRAF inhibitors at a very early stage. Understanding the molecular mechanisms involved in BRAF inhibitor resistance is critical for the development of novel therapeutic opportunities for this subtype of CRC patients. CRC cells bearing BRAF mutations are mostly sensitive to the abrogation of Mitogen-Activated Protein Kinase Kinase 3 (MKK3), a specific activator of p38MAPKs signaling, suggesting that BRAF alterations might addict CRC cells to the MKK3/p38MAPK signaling. Interestingly, publicly available gene expression profiling data show significantly higher MKK3 transcript levels in CRC lines with acquired resistance to BRAF inhibitors. Herein, we investigated the roles of MKK3 in the response to BRAF targeting (dabrafenib) with COLO205 and HT29 BRAF
    MeSH term(s) Humans ; Cell Line, Tumor ; Colorectal Neoplasms/drug therapy ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/metabolism ; Mutation/genetics ; Oximes/pharmacology ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Proto-Oncogene Proteins B-raf/genetics ; Proto-Oncogene Proteins B-raf/metabolism ; Signal Transduction ; MAP Kinase Kinase 3 ; Proto-Oncogene Proteins c-myc ; Drug Resistance, Neoplasm
    Chemical Substances dabrafenib (QGP4HA4G1B) ; Oximes ; Protein Kinase Inhibitors ; Proto-Oncogene Proteins B-raf (EC 2.7.11.1) ; MAP Kinase Kinase 3 (EC 2.7.12.2) ; Proto-Oncogene Proteins c-myc
    Language English
    Publishing date 2023-09-15
    Publishing country France
    Document type Journal Article
    ZDB-ID 392415-4
    ISSN 1950-6007 ; 0753-3322 ; 0300-0893
    ISSN (online) 1950-6007
    ISSN 0753-3322 ; 0300-0893
    DOI 10.1016/j.biopha.2023.115480
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top